USA - NYSE:MTD - US5926881054 - Common Stock
MTD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 56 industry peers in the Life Sciences Tools & Services industry. While MTD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MTD has a decent growth rate and is not valued too expensively.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 24.4% | ||
ROE | N/A | ||
ROIC | 39.61% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 28.61% | ||
PM (TTM) | 21.46% | ||
GM | 59.94% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 2.58 | ||
Altman-Z | 10.1 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.12 | ||
Quick Ratio | 0.77 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 30.73 | ||
Fwd PE | 26.89 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 30.54 | ||
EV/EBITDA | 22.81 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
1257.03
-1.02 (-0.08%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 30.73 | ||
Fwd PE | 26.89 | ||
P/S | 6.7 | ||
P/FCF | 30.54 | ||
P/OCF | 27.21 | ||
P/B | N/A | ||
P/tB | N/A | ||
EV/EBITDA | 22.81 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 24.4% | ||
ROE | N/A | ||
ROCE | 48.24% | ||
ROIC | 39.61% | ||
ROICexc | 40.71% | ||
ROICexgc | 70.2% | ||
OM | 28.61% | ||
PM (TTM) | 21.46% | ||
GM | 59.94% | ||
FCFM | 21.93% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 2.58 | ||
Debt/EBITDA | 1.73 | ||
Cap/Depr | 85.07% | ||
Cap/Sales | 2.69% | ||
Interest Coverage | 250 | ||
Cash Conversion | 77.47% | ||
Profit Quality | 102.18% | ||
Current Ratio | 1.12 | ||
Quick Ratio | 0.77 | ||
Altman-Z | 10.1 |